PMID- 10963760 OWN - NLM STAT- MEDLINE DCOM- 20001103 LR - 20191210 IS - 0028-3908 (Print) IS - 0028-3908 (Linking) VI - 39 IP - 11 DP - 2000 Aug 23 TI - Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. PG - 2170-9 AB - Neural sensorimotor gating mechanisms prevent the interruption of ongoing information processing routines by ensuing stimuli to permit mental integration and adaptive behavior. Prepulse inhibition (PPI), an operational measure of sensorimotor gating, is now being investigated using murine models to exploit transgenic and "knockout" technology. The present studies were undertaken to evaluate potential murine strain differences in the effects of serotonergic drugs on PPI and habituation. Two strains used most often as a genetic background for transgenic or knockout manipulations, C57BL/6 and 129Sv, and the outbred ICR strain were used. We assessed the effects of the 5-HT(1A/1B) agonist 5-methoxy-3(1,2,3,6)tetrahydropyridin-4-yl-1H-indole (RU24969), the 5-HT(1A) agonist 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT), the 5-HT(2A/2C) agonist (+/-)2,5-dimethoxy-4-methylamphetamine (DOM), and the serotonin releaser (+)3, 4-methylenedioxy-N-methylamphetamine (MDMA) on PPI and habituation of acoustic startle in the three strains. C57BL/6 mice exhibited lower baseline PPI levels than 129Sv and ICR mice, and 129Sv mice habituated less than C57BL/6 and ICR mice. MDMA decreased PPI in C57BL/6 and ICR, but not 129Sv mice, and RU24969 disrupted habituation in C57BL/6 and 129Sv, but not ICR mice. Lastly, RU24969 decreased and 8-OH-DPAT increased PPI across all strains, although qualitative differences were observed. Thus, both baseline and serotonergic drug-induced effects on murine PPI and habituation are strain-dependent. FAU - Dulawa, S C AU - Dulawa SC AD - Department of Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0804, USA. FAU - Geyer, M A AU - Geyer MA LA - eng GR - F31-MH12249-01/MH/NIMH NIH HHS/United States GR - R02 DA02925/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 RN - 0 (Serotonin Agents) SB - IM MH - Animals MH - Female MH - Habituation, Psychophysiologic/*drug effects/genetics MH - *Inhibition, Psychological MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred ICR MH - Reflex, Startle/*drug effects/genetics MH - Serotonin Agents/*pharmacology MH - Species Specificity EDAT- 2000/08/30 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/08/30 11:00 PHST- 2000/08/30 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/08/30 11:00 [entrez] AID - S0028390800000307 [pii] AID - 10.1016/s0028-3908(00)00030-7 [doi] PST - ppublish SO - Neuropharmacology. 2000 Aug 23;39(11):2170-9. doi: 10.1016/s0028-3908(00)00030-7.